NRC National Research Corporation
Healthcare$19.04-0.21%ClosedMarket Cap: $429.1M
As of 2026-05-26
Valuation
P/E (TTM)
33.42
PEG
—
P/B
30.82
P/S
3.10
EV/EBITDA
18.18
DCF Value
$13.74
FCF Yield
4.1%
Div Yield
2.9%
Margins & Returns
Gross Margin
55.9%
Operating Margin
14.1%
Net Margin
6.5%
ROE
57.2%
ROA
6.7%
ROIC
12.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $34.8M | 54.6% | $5.6M | $3.2M | $— | $0.32 |
| Q4 null | $35.2M | 54.3% | $4.7M | $1.8M | $— | $0.16 |
| FY null | $137.4M | 56.3% | $22.6M | $11.6M | $— | $0.64 |
| Q3 null | $34.6M | 57.8% | $7.7M | $4.1M | $— | $0.24 |
| Q2 null | $34.0M | 56.8% | $1.6M | $-106.0K | $— | $0.24 |
| Q1 null | $33.6M | 56.5% | $8.6M | $5.8M | $— | $0.24 |
| Q4 null | $36.9M | 61.1% | $9.6M | $6.6M | $— | $0.24 |
| FY null | $143.1M | 60.2% | $35.2M | $24.8M | $— | $0.60 |
| Q3 null | $35.8M | 57.3% | $8.0M | $5.7M | $— | $0.24 |
| Q2 null | $35.0M | 61.7% | $8.9M | $6.2M | $— | $0.24 |
| Q1 null | $35.3M | 60.8% | $8.8M | $6.4M | $— | $0.24 |
| Q4 2023 | $38.0M | 63.7% | $11.7M | $8.9M | $0.36 | $0.24 |